689 related articles for article (PubMed ID: 27981908)
1. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
Rao MRP; Chaudhari J; Trotta F; Caldera F
AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin based nanosponges for pharmaceutical use: a review.
Tejashri G; Amrita B; Darshana J
Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.
Ansari KA; Vavia PR; Trotta F; Cavalli R
AAPS PharmSciTech; 2011 Mar; 12(1):279-86. PubMed ID: 21240574
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of solubility enhancement, antioxidant activity, and cytotoxicity studies of kynurenic acid loaded cyclodextrin nanosponge.
Dhakar NK; Caldera F; Bessone F; Cecone C; Pedrazzo AR; Cavalli R; Dianzani C; Trotta F
Carbohydr Polym; 2019 Nov; 224():115168. PubMed ID: 31472867
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin based nanosponge of norfloxacin: Intestinal permeation enhancement and improved antibacterial activity.
Mendes C; Meirelles GC; Barp CG; Assreuy J; Silva MAS; Ponchel G
Carbohydr Polym; 2018 Sep; 195():586-592. PubMed ID: 29805015
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin Based Nanosponges: A Multidimensional Drug Delivery System and its Biomedical Applications.
Mane PT; Wakure BS; Wakte PS
Curr Drug Deliv; 2021; 18(10):1467-1493. PubMed ID: 33902410
[TBL] [Abstract][Full Text] [Related]
8. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
9. Nanosponge formulations as oxygen delivery systems.
Cavalli R; Akhter AK; Bisazza A; Giustetto P; Trotta F; Vavia P
Int J Pharm; 2010 Dec; 402(1-2):254-7. PubMed ID: 20888402
[TBL] [Abstract][Full Text] [Related]
10. Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment.
Swaminathan S; Vavia PR; Trotta F; Cavalli R
J Biomed Nanotechnol; 2013 Jun; 9(6):998-1007. PubMed ID: 23858964
[TBL] [Abstract][Full Text] [Related]
11. Role of cyclodextrins in ophthalmics.
Kaur IP; Chhabra S; Aggarwal D
Curr Drug Deliv; 2004 Oct; 1(4):351-60. PubMed ID: 16305397
[TBL] [Abstract][Full Text] [Related]
12. Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges.
Shoaib QU; Latif S; Ijaz QA; Afzal H; Siddique MI; Hussain A; Arshad MS; Bukhari NI; Abbas N
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1045-1055. PubMed ID: 34602431
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-based nanosponges: A critical review.
Sherje AP; Dravyakar BR; Kadam D; Jadhav M
Carbohydr Polym; 2017 Oct; 173():37-49. PubMed ID: 28732878
[TBL] [Abstract][Full Text] [Related]
14. Encapsulating curcumin in ethylene diamine-β-cyclodextrin nanoparticle improves topical cornea delivery.
Liu CH; Lee GW; Wu WC; Wang CC
Colloids Surf B Biointerfaces; 2020 Feb; 186():110726. PubMed ID: 31862560
[TBL] [Abstract][Full Text] [Related]
15. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
16. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability.
Gabr MM; Mortada SM; Sallam MA
Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular cyclodextrin complex: Diversity, safety, and applications in ocular therapeutics.
Chaudhari P; Ghate VM; Lewis SA
Exp Eye Res; 2019 Dec; 189():107829. PubMed ID: 31605685
[TBL] [Abstract][Full Text] [Related]
18. The application of nanosponges to cancer drug delivery.
Trotta F; Dianzani C; Caldera F; Mognetti B; Cavalli R
Expert Opin Drug Deliv; 2014 Jun; 11(6):931-41. PubMed ID: 24811423
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery.
Chilajwar SV; Pednekar PP; Jadhav KR; Gupta GJ; Kadam VJ
Expert Opin Drug Deliv; 2014 Jan; 11(1):111-20. PubMed ID: 24298891
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin-based nanosponges as drug carriers.
Trotta F; Zanetti M; Cavalli R
Beilstein J Org Chem; 2012; 8():2091-9. PubMed ID: 23243470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
